Sort
50,496 grants matching “lung cancer”
Design and characterization of bacterial population dynamics in solid tumor models
$628,437Jeff M Hasty · University Of California, San Diego · R01 · FY2023 · EB
Design and characterization of bacterial population dynamics in solid tumor models
$628,437Jeff M Hasty · University Of California, San Diego · R01 · FY2022 · EB
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
$628,354Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2024 · CA
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
$628,307Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
MODELING THE POLICY IMPACT OF CIGARETTE AND SMOKELESS USE ON US MORTALITY
$628,295David T Levy · Georgetown University · R01 · FY2015 · DA
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$628,294Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
$628,281Yutaka Yasui · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
$628,281Yutaka Yasui · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer care
$628,231Cary P Gross · Yale University · R01 · FY2024 · CA
Personalized Task-Based Respiratory Motion Correction for Low-Dose PET/CT
$628,203Chi Liu · Yale University · R01 · FY2022 · CA
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients
$628,081Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2018 · CA
Precision magnetic hyperthermia by integrating magnetic particle imaging
$628,016Jeff W Bulte · Johns Hopkins University · R01 · FY2025 · CA
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States
$627,947Meira Epplein · Duke University · R01 · FY2023 · CA
Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer
$627,924Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
OVERCOMING LUNG CANCER IMMUNOTHERAPY RESISTANCE BY TARGETING BONE MORPHOGENETIC PROTEINS
$627,906The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment
$627,896Arnold L Potosky · Georgetown University · U01 · FY2024 · CA
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$627,890Nicholas C Denko · Ohio State University · R01 · FY2023 · CA
Construction of A Lung Cancer Preclinical Model Cross-comparison Platform
$627,833Ling Cai · Ut Southwestern Medical Center · R01 · FY2024 · CA
iPSC-based blood regenerative therapies for AIDS
$627,832Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2014 · HL
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
$627,805Marc Elliott Lenburg · Boston University Medical Campus · R01 · FY2020 · CA
Pharmacogenetic Studies
$627,804Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Cancer Caregivers and Their Struggle(s) between Work and Family
$627,771Mark L. Laudenslager · University Of Colorado Denver · R01 · FY2019 · CA
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial
$627,768Lee W Jones · Duke University · R01 · FY2012 · CA
Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy
$627,705Ruijiang Li · Stanford University · R01 · FY2024 · CA
VERMONT INBRE: LEAD INSTITUTION CORE
$627,617Judith L Van Houten · University Of Vermont & St Agric College · P20 · FY2010 · RR